Come up with a name for your new list and we'll add to it:
Valerion Therapeutics raised a round of funding on June 18, 2010. Investors include
Massachusetts Life Sciences Center.
Valerion Therapeutics, formelry 4s3 Bioscience, is a biotechnology company focused on developing genetic disease therapies for orphan neuromuscular disorders. The company's platform is an antibody-bas…